Approval · Notice of Compliance 24296 · 2020
FIRDAPSE: Notice of Compliance 24296
Issued September 24, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24296
- Date
- September 24, 2020
- Company
- Kye Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FIRDAPSE | 02502984 | Marketed |
Medicinal ingredients
- AMIFAMPRIDINE PHOSPHATE 10 MG per TAB